Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacotherapy for end-stage coronary artery disease.

Literature DB >> 20088742

Pharmacotherapy for end-stage coronary artery disease.

Neel R Sodha¹, Louis M Chu, Munir Boodhwani, Frank W Sellke.

Abstract

IMPORTANCE OF THE FIELD: Coronary artery disease remains the leading cause of mortality in the industrialized world. Despite advances in surgical and catheter-based interventions, a select number of patients remain with no options for invasive therapy. The goal of this review is to discuss the current status of pharmacotherapeutic interventions to treat end-stage coronary artery disease. AREAS COVERED IN THIS REVIEW: Literature review on the topic of therapeutic angiogenesis from 1980 to 2009. WHAT THE READER WILL GAIN: Insight into current therapeutic strategies employed to manage end-stage coronary artery disease. TAKE HOME MESSAGE: A promising approach focuses on augmenting the endogenous angiogenic response to chronic myocardial ischemia via the use of growth factors.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20088742 PMCID： PMC2811321 DOI： 10.1517/14656560903439737

Source DB: PubMed Journal: Expert Opin Pharmacother ISSN： 1465-6566 Impact factor: 3.889

62 in total

1. Opposite effects of pre- and postischemic treatments with nitric oxide donor on ischemia/reperfusion-induced renal injury.

Authors: Atsushi Nakajima; Kyoko Ueda; Masanori Takaoka; Yoshiko Yoshimi; Yasuo Matsumura
Journal: J Pharmacol Exp Ther Date: 2005-11-23 Impact factor: 4.030

2. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Authors: T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; D W Losordo; R C Hendel; R O Bonow; S M Eppler; T F Zioncheck; E B Holmgren; E R McCluskey
Journal: Am Heart J Date: 2001-11 Impact factor: 4.749

3. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors: Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal: N Engl J Med Date: 2006-09-21 Impact factor: 91.245

4. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

Authors: B Schumacher; P Pecher; B U von Specht; T Stegmann
Journal: Circulation Date: 1998-02-24 Impact factor: 29.690

5. Effects of erythropoietin on cardiac remodeling after myocardial infarction.

Authors: Daisuke Nishiya; Takashi Omura; Kenei Shimada; Ryo Matsumoto; Takanori Kusuyama; Soichiro Enomoto; Hiroshi Iwao; Kazuhide Takeuchi; Junichi Yoshikawa; Minoru Yoshiyama
Journal: J Pharmacol Sci Date: 2006-05 Impact factor: 3.337

6. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction.

Authors: Pierre Voisine; Cesario Bianchi; Tanveer A Khan; Marc Ruel; Shu-Hua Xu; Jun Feng; Jian Li; Tamer Malik; Audrey Rosinberg; Frank W Sellke
Journal: J Thorac Cardiovasc Surg Date: 2005-06 Impact factor: 5.209

7. Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor.

Authors: R J Tomanek; M K Doty; A Sandra
Journal: Circ Res Date: 1998-03-23 Impact factor: 17.367

8. Statin use is associated with enhanced collateralization of severely diseased coronary arteries.

Authors: Isaac Pourati; Carey Kimmelstiel; William Rand; Richard H Karas
Journal: Am Heart J Date: 2003-11 Impact factor: 4.749

Review 9. Pharmacological approaches to improve endothelial repair mechanisms.

Authors: Christian Besler; Carola Doerries; Giovanna Giannotti; Thomas F Lüscher; Ulf Landmesser
Journal: Expert Rev Cardiovasc Ther Date: 2008-09

10. Analysis of progenitor cell mobilization and erythropoietin plasma levels in patients with acute myocardial infarction.

Authors: Korff Krause; Boris Fehse; Kai Jaquet; Claudia Lange; Konstantin Kyriazis; Sigrid Boczor; Axel Zander; Karl-Heinz Kuck
Journal: Exp Clin Cardiol Date: 2005

5 in total

1. Cytoprotective and proangiogenic activity of ex-vivo netrin-1 transgene overexpression protects the heart against ischemia/reperfusion injury.

Authors: Shazia Durrani; Khawaja Husnain Haider; Rafeeq P H Ahmed; Shujia Jiang; Muhammad Ashraf
Journal: Stem Cells Dev Date: 2011-11-11 Impact factor: 3.272

Review 2. Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles.

Authors: Michael P Robich; Louis M Chu; Shizu Oyamada; Neel R Sodha; Frank W Sellke
Journal: Expert Rev Cardiovasc Ther Date: 2011-11

3. Resveratrol supplementation abrogates pro-arteriogenic effects of intramyocardial vascular endothelial growth factor in a hypercholesterolemic swine model of chronic ischemia.

Authors: Louis M Chu; Michael P Robich; Antonio D Lassaletta; Jun Feng; Roger J Laham; Thomas Burgess; Richard T Clements; Frank W Sellke
Journal: Surgery Date: 2011-07-23 Impact factor: 3.982

4. Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia.

Authors: Michael P Robich; Robina Matyal; Louis M Chu; Jun Feng; Shu-Hua Xu; Roger J Laham; Philip E Hess; Cesario Bianchi; Frank W Sellke
Journal: J Mol Cell Cardiol Date: 2010-09-06 Impact factor: 5.000

5. Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.

Authors: Ming Wu; Peter Pokreisz; Melissa Swinnen; Ellen Caluwe; Hilde Gillijns; Nina Vanden Driessche; Andrea Casazza; Erik Verbeken; Desire Collen; Stefan Janssens
Journal: J Cardiovasc Transl Res Date: 2017-04-10 Impact factor: 4.132

5 in total